ASP Isotopes Inc.
ASPI- Exchange
- Nasdaq
- Industry
- Miscellaneous Chemical Products
- SEC CIK
- 0001921865
In the last 90 days, ASP Isotopes Inc. insiders filed 2 open-market purchases and 7 sales; 160 institutions reported holding it in 13F filings for Q3 2026, worth $165.1M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 17, 2026, 2:23 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $159.8M (670.2% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – |
| Revenue | $23.8M | $4.14M | $433.0K | – |
| Cost of revenue | $20.4M | $2.54M | $294.1K | – |
| Gross profit | $3.40M | $1.60M | $139.0K | – |
| Operating expenses | $63.3M | $28.0M | $16.2M | $5.10M |
| Research and development | $12.4M | $3.14M | $764.6K | $1.27M |
| Selling, general and administrative | $48.2M | $24.8M | $15.4M | $3.83M |
| Operating income | -$59.9M | -$26.4M | -$16.0M | -$5.10M |
| Interest expense | $9.38K | $17.9K | $118.5K | – |
| Income tax | $282.0K | $111.4K | -$6.13K | $0 |
| Net income | -$159.8M | -$32.4M | -$16.3M | -$4.95M |
| EPS, basic | $-2.11 | $-0.63 | $-0.49 | $-0.18 |
| EPS, diluted | $-2.11 | $-0.63 | – | – |
| Weighted shares, basic | 83.0M | 55.7M | – | 26.8M |
| Weighted shares, diluted | 83.0M | 55.7M | – | – |
| Margins and growth | ||||
| Gross margin | 14.3% | 38.6% | 32.1% | – |
| Operating margin | -251.2% | -635.9% | -3704.6% | – |
| Net margin | -670.2% | -782.4% | -3762.9% | – |
| Revenue growth, year over year | +475.5% | +857.0% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – |
| Cash and equivalents | $285.6M | $61.9M | – | $2.39M |
| Short-term investments | $47.7M | – | – | – |
| Inventory | $1.10M | $65.7K | – | – |
| Total current assets | $399.9M | $65.7M | $10.5M | $3.30M |
| Property, plant and equipment | $33.5M | $22.4M | $10.7M | $8.20M |
| Goodwill | $8.57M | $3.17M | $3.27M | – |
| Intangible assets | $1.48M | – | – | – |
| Total assets | $498.0M | $94.3M | $27.5M | $12.5M |
| Accounts payable | $5.75M | $1.02M | $1.11M | $1.35M |
| Short-term debt | $12.9M | – | – | – |
| Total current liabilities | $32.7M | $7.06M | $5.67M | $1.94M |
| Long-term debt | $1.47M | – | – | – |
| Total liabilities | $235.1M | $43.2M | $8.71M | $2.68M |
| Shareholders' equity | $262.9M | $51.2M | $18.8M | $9.82M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – |
| Operating cash flow | -$37.8M | -$16.7M | -$5.41M | -$2.94M |
| Capital expenditures | $9.65M | $9.68M | $2.33M | $4.47M |
| Free cash flow | -$47.4M | -$26.4M | -$7.74M | -$7.41M |
| Depreciation and amortization | $1.91M | – | – | – |
| Stock-based compensation | $16.0M | $8.56M | $8.74M | $2.00M |
| Dividends paid | $0 | $2.78M | – | – |
| Investing cash flow | -$110.8M | -$11.4M | -$2.45M | -$4.47M |
| Financing cash flow | $371.6M | $82.5M | $13.4M | $6.64M |
| Net change in cash | – | – | $5.52M | – |
| Ratio | ||||
| Stock-based compensation, % of revenue | 67.2% | 206.6% | 2019.2% | – |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 16, 2026 | 155.8M | +40.6% | SEC |
| Aug 14, 2026 | 153.3M | +66.8% | SEC |
| May 20, 2026 | 125.9M | +67.7% | SEC |
| Apr 6, 2026 | 125.9M | +74.7% | SEC |
| Nov 19, 2025 | 110.8M | +55.3% | SEC |
| Aug 14, 2025 | 91.9M | +37.8% | SEC |
| May 20, 2025 | 75.1M | +45.0% | SEC |
| Mar 31, 2025 | 72.1M | +47.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.